ID: ALA3968387

Max Phase: Preclinical

Molecular Formula: C19H13F2NO4

Molecular Weight: 357.31

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=C(c1ccc(F)c(O)c1)c1cc(CO)cc(-c2cccc(O)c2F)n1

Standard InChI:  InChI=1S/C19H13F2NO4/c20-13-5-4-11(8-17(13)25)19(26)15-7-10(9-23)6-14(22-15)12-2-1-3-16(24)18(12)21/h1-8,23-25H,9H2

Standard InChI Key:  AGLYTRDSFIYAQW-UHFFFAOYSA-N

Associated Targets(Human)

17-beta-hydroxysteroid dehydrogenase 14 155 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 357.31Molecular Weight (Monoisotopic): 357.0813AlogP: 3.16#Rotatable Bonds: 4
Polar Surface Area: 90.65Molecular Species: NEUTRALHBA: 5HBD: 3
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: 7.46CX Basic pKa: 0.69CX LogP: 3.54CX LogD: 3.24
Aromatic Rings: 3Heavy Atoms: 26QED Weighted: 0.62Np Likeness Score: -0.04

References

1. Braun F, Bertoletti N, Möller G, Adamski J, Steinmetzer T, Salah M, Abdelsamie AS, van Koppen CJ, Heine A, Klebe G, Marchais-Oberwinkler S..  (2016)  First Structure-Activity Relationship of 17β-Hydroxysteroid Dehydrogenase Type 14 Nonsteroidal Inhibitors and Crystal Structures in Complex with the Enzyme.,  59  (23): [PMID:27933965] [10.1021/acs.jmedchem.6b01436]

Source